{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:51:21Z","timestamp":1785898281483,"version":"3.56.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG3B1471-3"],"award-info":[{"award-number":["CMRPG3B1471-3"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG3H0761-3"],"award-info":[{"award-number":["CMRPG3H0761-3"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2020.00330","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T12:05:10Z","timestamp":1587729910000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Shifting Valproic Acid to Levetiracetam in Women of Childbearing Age With Epilepsy: A Retrospective Investigation and Review of the Literature"],"prefix":"10.3389","volume":"11","author":[{"given":"Cheng-Yen","family":"Kuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Jun","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huei-Shyong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Cheng","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Liang","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jainn-Jim","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Yun","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Ying","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Shan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuang-Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.contraception.2008.02.002","article-title":"Reproductive history, sexual behavior and use of contraception in women with epilepsy","volume":"77","author":"Davis","year":"2008","journal-title":"Contraception"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1111\/epi.13437","article-title":"Withdrawal of valproic acid treatment during pregnancy and seizure outcome: Observations from EURAP","volume":"57","author":"Tomson","year":"2016","journal-title":"Epilepsia"},{"key":"B3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.yebeh.2017.10.017","article-title":"Predicting epileptic seizure control during pregnancy","volume":"78","author":"Vajda","year":"2018","journal-title":"Epilepsy Behav"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/S0140-6736(68)91781-9","article-title":"Anticonvulsant drugs and congenital abnormalities","volume":"2","author":"Meadow","year":"1968","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1212\/WNL.0b013e31821ccd18","article-title":"Final results from 18 years of the International Lamotrigine Pregnancy Registry","volume":"76","author":"Cunnington","year":"2011","journal-title":"Neurology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1212\/01.wnl.0000316199.92256.af","article-title":"Pregnancy registries in epilepsy: a consensus statement on health outcomes","volume":"71","author":"Meador","year":"2008","journal-title":"Neurology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.jocn.2010.05.008","article-title":"The australian pregnancy register of anti-epileptic drugs : 10 years of progress","volume":"17","author":"Vajda","year":"2010","journal-title":"J Clin Neurosci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s00115-006-2082-2","article-title":"EURAP","volume":"77","author":"Kretz","year":"2006","journal-title":"Nervenarzt"},{"key":"B9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","article-title":"Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register","volume":"77","author":"Morrow","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1111\/j.0013-9580.2004.451102.x","article-title":"North american antiepileptic drug pregnancy registry","volume":"45","author":"Holmes","year":"2004","journal-title":"Epilepsia"},{"key":"B11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S1474-4422(18)30495-2","article-title":"Management of epilepsy in women","volume":"18","author":"Stephen","year":"2019","journal-title":"Lancet Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1212\/WNL.0000000000001182","article-title":"IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study","volume":"84","author":"Baker","year":"2015","journal-title":"Neurology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","article-title":"Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study","volume":"12","author":"Meador","year":"2013","journal-title":"Lancet Neurol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.yebeh.2013.08.001","article-title":"Fetal antiepileptic drug exposure: adaptive and emotional\/behavioral functioning at age 6years","volume":"29","author":"Cohen","year":"2013","journal-title":"Epilepsy Behav"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/epi.13007","article-title":"Prospective assessment of autism traits in children exposed to antiepileptic drugs during pregnancy","volume":"56","author":"Wood","year":"2015","journal-title":"Epilepsia"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"key":"B17","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1212\/WNL.0000000000001772","article-title":"Dose-dependent teratogenicity of valproate in mono- and polytherapy","volume":"85","author":"Tomson","year":"2015","journal-title":"Neurology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/j.1471-0528.2009.02141.x","article-title":"The management of epilepsy in pregnancy","volume":"116","author":"Walker","year":"2009","journal-title":"BJOG An Int J Obstet Gynaecol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.seizure.2015.02.019","article-title":"Major congenital malformations in children of women with epilepsy","volume":"28","author":"Tomson","year":"2015","journal-title":"Seizure"},{"key":"B20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.seizure.2007.07.001","article-title":"Levetiracetam monotherapy in juvenile myoclonic epilepsy","volume":"17","author":"Sharpe","year":"2008","journal-title":"Seizure"},{"key":"B21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.5698\/1535-7597-14.5.255","article-title":"Monotherapy in newly diagnosed epilepsy: levetiracetam versus standard anticonvulsants","volume":"14","author":"Koubeissi","year":"2014","journal-title":"Epilepsy Curr"},{"key":"B22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.5698\/1535-7597-13.6.279","article-title":"Levetiracetam: more evidence of safety in pregnancy","volume":"13","author":"Koubeissi","year":"2013","journal-title":"Epilepsy Curr"},{"key":"B23","unstructured":"BanchhorSK\n            LondheND\n            ArakiT\n            SabaL\n            RadevaP\n            KhannaNN\n          Reproductive Health Indicators. Guidelines for Their Generation, Interpretation Analysis for Global Monitoring2006"},{"key":"B24","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.seizure.2012.08.008","article-title":"Levetiracetam-associated aggravation of myoclonic seizure in children","volume":"21","author":"Liu","year":"2012","journal-title":"Seizure"},{"key":"B25","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ejpn.2011.05.007","article-title":"Aggravation of absence seizure related to levetiracetam","volume":"15","author":"Auvin","year":"2011","journal-title":"Eur J Paediatr Neurol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1528-1167.2012.03652.x","article-title":"Seizure recurrence and remission after switching antiepileptic drugs","volume":"54","author":"Wang","year":"2013","journal-title":"Epilepsia"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.eplepsyres.2013.08.016","article-title":"Metabolic and endocrine effects of valproic acid chronic treatment","volume":"107","author":"Belcastro","year":"2013","journal-title":"Epilepsy Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"926","DOI":"10.2174\/1570159X17666181227165722","article-title":"Valproic acid and epilepsy: from molecular mechanisms to clinical evidences","volume":"17","author":"Belcastro","year":"2019","journal-title":"Curr Neuropharmacol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.reprotox.2009.02.014","article-title":"Valproic acid in pregnancy: how much are we endangering the embryo and fetus?","volume":"28","author":"Ornoy","year":"2009","journal-title":"Reprod Toxicol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"479364","DOI":"10.1111\/j.1753-4887.1952.tb01010.x","article-title":"Molecular and therapeutic potential and toxicity of valproic acid","volume":"2010","author":"Chateauvieux","year":"2010","journal-title":"J Biomed Biotechnol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00330\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T12:05:14Z","timestamp":1587729914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2020.00330\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,24]]},"references-count":30,"alternative-id":["10.3389\/fneur.2020.00330"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2020.00330","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,24]]},"article-number":"330"}}